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Abstract 12 
Genotoxic carcinogens are present in the human diet, and two important examples are 13 
benzo[a]pyrene (BaP) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). BaP is a 14 
polycyclic aromatic hydrocarbon generated by incomplete combustion of organic substances, thus 15 
contaminating numerous foodstuffs, and PhIP is a heterocyclic amine formed when meat is cooked. 16 
Genotoxicity testing of chemical carcinogens has focussed largely on individual chemicals, 17 
particularly in relation to diet, despite mixtures representing a more realistic exposure scenario. We 18 
have previously shown that exposure of MCL-5 cells to BaP-PhIP mixtures produces a TK mutation 19 
dose response that differs from the predicted additive response, using traditional regulatory-like 20 
two-dimensional (2D) cell culture. There is a large gap between 2D cell culture and the whole animal, 21 
and three-dimensional (3D) cell culture, shown to better represent in vivo tissue structure, may 22 
bridge the gap. The aim of the current study was to use 3D spheroids to characterise the DNA 23 
damage response following exposure to mixtures of the mammary carcinogens BaP and PhIP. 24 
Mammary MCF-7 cells were grown in 3D spheroids, exposed (24h) to BaP (10
-10
 to 10
-5
M) or PhIP 25 
(10
-9
 to 10
-4
M) individually or in mixtures and DNA damage assessed by micronucleus (MN) 26 
formation. A dose-dependent increase in MN was observed for the individual chemicals in 3D cell 27 
culture. In line with our previous 2D TK mutation data, 3D mixture exposures gave a modified DNA 28 
damage profile compared to the individual chemicals, with a potent response at low dose 29 
combinations and a decrease in MN with higher concentrations of BaP in the mixture. 30 
Ethoxyresorufin-O-deethylase (CYP1A) activity increased with increasing concentration of BaP in the 31 
mixture, and for combinations with 10µM BaP, CYP1A1 mRNA induction was sustained up to 48h. 32 
These data suggest mixtures of genotoxic chemicals give DNA damage responses that differ 33 
considerably from those produced by the chemicals individually, and that 3D cell culture is an 34 
appropriate platform for DNA damage assays. 35 
 36 
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Introduction 37 
Cooking food at high temperatures produces genotoxic carcinogens that present a concern for 38 
human health. The consumption of red meat, is positively correlated with human cancer and cooking 39 
meat produces heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) 
1
. Two 40 
important examples are the PAH benzo[a]pyrene (BaP) and the HA 2-amino-1-methyl-6-41 
phenylimidazo[4,5-b]pyridine (PhIP). BaP is generated by incomplete combustion of organic 42 
substances, such as lipids, resulting in the contamination of numerous foodstuffs 
2
.BaP is 43 
metabolised primarily by the Cytochrome P450 (CYP) 1A family to epoxides including the BaP-diol 44 
epoxide (BPDE) derivative that can form DNA adducts and result in mutation and tumours 
3
. Through 45 
consumption of contaminated food, average human daily exposure to BaP is estimated to be about 46 
1-500ng 
3
. Evidence from numerous experimental studies suggests a positive link between exposure 47 
to BaP and cancer in animals and in humans 
1
. PhIP is extensively bioavailable, with daily ingestion 48 
being 0.1–15µg  
4, 5
, and is an established rodent carcinogen 
6
 inducing cancer in the prostate, colon, 49 
and mammary gland of rats 
7, 8
. PhIP is activated via N-hydroxylation catalysed by CYP1A1 and 1A2 to 50 
DNA damaging species 
8-10
. 51 
Mixtures of food-derived genotoxic carcinogens represent a more realistic dietary exposure 52 
scenario, however, published assessment of genotoxic carcinogens, particularly dietary carcinogens, 53 
in mixtures is limited. Recently we have shown that mixtures of BaP with PhIP produced non-54 
monotonic mutation responses at the TK locus in MCL-5 cells (metabolically competent 55 
lymphoblastoid) 
11
. Most notably, combinations of low concentrations (individually not detectably 56 
mutagenic) showed synergism, while antagonism was observed for high concentration combinations 57 
(significantly mutagenic alone). These mutation profiles, particularly the synergism at low 58 
concentration combinations (relevant to human exposure), are of significance when considering the 59 
genotoxic potential of food, and potentially risk assessment. However, these data were obtained 60 
using two dimensional (2D) cell culture, which is not representative of the cellular environment 61 
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found within an organism. Three dimensional (3D) cell cultures have been shown to better represent 62 
the in vivo structure of tissues 
12
 (Figure 1), thus culturing in 3D may decrease the gap between cell 63 
culture and physiological tissue 
13
. Current genotoxicity testing adopts a tiered approach: structural 64 
activity relationships, bacterial Ames tests and mammalian cell culture, before testing in vivo. The 65 
gap between cell culture and whole animal is large and we propose that 3D cell culture may bridge 66 
that gap. The aim of the current study was to use 3D organotypic cell culture to characterise the 67 
DNA damage response following exposure to BaP and PhIP, individually and in mixtures. 68 
Methods 69 
Materials 70 
Minimal essential medium (MEM) (without phenol red, or L-glutamine), foetal bovine serum (FBS), L-71 
glutamine, penicillin/streptomycin, and non-essential amino acids (NEAA) were obtained from Life 72 
Technologies, Paisley, UK. All other chemicals were purchased from Sigma-Aldrich, Poole, UK unless 73 
otherwise stated. 74 
Cell culture 75 
MCF-7 cells, obtained from ATCC, were cultured in MEM supplemented with 10% (v/v) FBS, 2mM L-76 
glutamine, 100units/ml penicillin, 100µg/ml streptomycin, 2x NEAA, (called M10 media). Cells were 77 
cultured in a humidified incubator with 5% CO2, at 37°C.  78 
Three dimensional (3D) spheroid culture 79 
MCF-7 cells (10
6
)
 
were seeded in AlgiMatrix scaffolds (Life Technologies) contained in 24 well plates 80 
following manufacturer’s instructions. Cells were monitored and culture medium routinely changed. 81 
Cells were incubated for 15 days to establish 3D structures with ultrastructural and physiological 82 
traits and capabilities closer to those seen in the intact tissue or organ 
14
. To isolate spheroids from 83 
Page 10 of 25Toxicology Research
5 
 
the scaffold, matrix dissolving buffer (Life Technologies) was used following manufacturer’s 84 
instructions followed by standard trypsinisation to generate single cell suspensions when required. 85 
Adenylate kinase assay for cell viability 86 
Viability of spheroid cultures was assessed by measuring adenylate kinase (AK) in spent media using 87 
the bioluminescent cytotoxicity assay kit (Lonza Toxilight assay kit) following manufacturer’s 88 
instructions. 89 
Micronucleus (MN) assay 90 
Following the 15 day incubation period in AlgiMatrix scaffolds, spheroids were treated with with BaP 91 
or PhIP or binary mixtures (all prepared in DMSO) to achieve the following final concentrations: BaP 92 
(10
-10
-10
-5
M), PhIP (10
-9
 – 10
-4
M), BaP+PhIP (10
-9
+10
-9
M, 10
-7
+10
-6
M, 10
-6
+10
-6
M, 10
-6
+10
-5
M, 10
-5
+10
-
93 
6
M, 10
-5
+10
-4
M). Dimethylsulfoxide (DMSO; 0.1% v/v) was the negative control and etoposide 94 
(10µg/ml) the positive control. Cells were treated for 24h in M10 at 37°C, 5% CO2. Following 95 
treatment, spheroids were washed twice with fresh media and maintained for a 48h recovery period 96 
at the end of which cells were counted, adjusted to 4x10
5
/ml in M10 containing 2% pluronic (Life 97 
Technologies) and deposited directly onto slides using a cytospin centrifuge. Cells were fixed in 100% 98 
methanol and stained with acridine orange. The frequency of MN in mononuclear cells was scored 99 
blind in a minimum of 1000 cells per sample, two to three independent cultures were used per 100 
treatment. 101 
Ethoxyresorufin-O-deethylase activity (EROD) 102 
Ethoxyresorufin-O-deethylase (EROD), an indicator of CYP1A activity, was measured in a dynamic 103 
fluorescent assay by the conversion of added 7-ethoxyresorufin (7-ER) to resorufin. MCF-7 spheroids 104 
(incubated in AlgiMatrix scaffold for 15 days) were treated with BaP alone or selected combinations 105 
of BaP with PhIP for 24h following which spheroids were washed twice with fresh medium, 8µM 7-106 
ER added, and the plate incubated for 90 minutes at 37°C. Fluorescence was measured at λexcitation 107 
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560nm and λemission 590nm every 10 minutes using a fluorescence plate reader (POLARstar Galaxy, 108 
BMG Lab Technologies). Activity was expressed as pmol resorufin produced/min/mg protein cells 109 
using a resorufin standard curve. 110 
Protein Determination 111 
Spheroids were isolated from the scaffold using matrix dissolving buffer (Life Technologies) following 112 
manufacturer’s instructions. Isolated spheroids were treated with RIPA buffer (Sigma) with the 113 
addition of 1x Halt protease inhibitor cocktails 1 and 2 (Life Technologies) for 30 minutes on ice. The 114 
lysate was clarified by centrifugation (8000xg, 10 minutes, 4°C), the supernatant collected and 115 
stored at -20°C. The protein concentration of the lysate was determined using the BCA assay (Pierce, 116 
Thermo Scientific) following manufacturer’s instructions.  117 
RNA Extraction and Quantitative RT-PCR (Q-PCR) 118 
Following isolation of cells for MN determination, the remaining cells were collected by 119 
centrifugation (200xg, 5 minutes, RT) and the cell pellet resuspended in 0.5ml Trizol (Invitrogen, 120 
Paisley, UK) for RNA extraction following manufacturer’s instructions with the addition of two extra 121 
ethanol washes. RNA was quantified using a NanoPhotometer (Implen GmbH, Munchen, Germany) 122 
and the ratios A260/280 and A260/230 used to assess quality. To synthesise cDNA 1µl random 123 
primers was added to 500ng of RNA (made up to a final volume of 15µl with RNase/DNase-free 124 
dH2O) and incubated at 65°C for 5 minutes. The mixture was placed on ice before the addition of 125 
0.2mM dNTPs, 5µl 5x first strand buffer, 2µl 0.1mM DTT and 0.5µl Superscript II reverse 126 
transcriptase (all from Superscript II kit, Life Technologies). The samples were run on a thermocycler 127 
(25°C for 10 minutes, 42°C for 90 minutes and 70°C for 15 minutes). CYP1A1 cDNA was amplified 128 
using Q-PCR. As an internal standard, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA 129 
fragments were also amplified. TaqMan gene expression assays were purchased from Life 130 
Technologies and the generated cDNA amplified using the Taqman Fast 2x Universal PCR master mix, 131 
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No AmpErase UNG (Life Technologies), with each reaction performed in triplicate. The Q-PCR data 132 
were analysed using the ABI 7500 Sequence Detection System (Life Technologies) and the 133 
comparative Ct Method (ΔCT Method) 
15
. Calibration was based on the expression of GAPDH. 134 
 135 
Results 136 
Micronucleus assay  137 
Optimisation of recovery period 138 
The recovery period for a MN assay is typically 24h, which allows the cells to undergo at least one 139 
complete division. However, we have previously optimised the recovery time for MCF-7 cells in 2D as 140 
48h and it has previously been demonstrated in our lab that HCT116 cells require a 72h recovery 141 
period 
16
. As the growth rate of MCF-7 cells in 3D is likely to differ from those growing in 2D, it was 142 
important to establish whether a 48h recovery time was appropriate. Following a 24h treatment 143 
with 10
-5
M BaP, an induction of 22.5 MN per 1000 cells above control was observed following a 48h 144 
recovery, whereas an induction of only 13.5 MN per 1000 cells was observed following a 72h 145 
recovery (Table 1). Moreover, the number of MN per 1000 cells in the DMSO control increased from 146 
3.5 following a 48h recovery period to 17.8 following a 72h recovery period (Table 1).  Thus a 147 
recovery period of 48h was chosen. 148 
Individual chemicals 149 
The concentrations of BaP and PhIP used were chosen to cover a range that went from typical 150 
human dietary exposure (<10
-8
M) 
1, 3, 17
 to high concentrations previously shown in our laboratory 151 
and elsewhere to induce a genotoxic response 
4, 18-20
. BaP produced a statistically significant increase 152 
in micronuclei (Figure 2A), while treatment of cells with PhIP required higher doses to induce MN 153 
(Figure 2B). At doses of BaP >10
-7
 M, the cell viability decreased, consistent with BaP metabolite 154 
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induced cytotoxicity. For PhIP, viability was maintained over the dose range employed. However, 155 
viability did not fall below 70% for either compound (Figure 2), and was thus within the accepted 156 
range for the assay as determined by OECD 
21
. 157 
Mixtures of BaP and PhIP 158 
The observed MN induction for the tested combinations of BaP with PhIP differed from the response 159 
observed for the individual chemicals, with a greater induction of MN observed for the combination 160 
of 10
-7
M BaP with 10
-6
M PhIP than for the highest concentration combination tested, 10
-5
M BaP with 161 
10
-4
M PhIP (Figure 3a and b). A significant decrease in the number of MN was observed from the 162 
combination 10
-7
M BaP with 10
-6
M PhIP to the combination 10
-5
M BaP with 10
-4
M PhIP (Figure 3a 163 
and b). 164 
EROD activity 165 
Both BaP and PhIP require metabolic activation to a genotoxic product catalysed by the CYP1A 166 
family. EROD activity was measured as an indicator of CYP1A activity in cells treated with the BaP-167 
PhIP mixtures. The results show induction of EROD activity by BaP alone (Figure 4a) and the tested 168 
combinations of BaP and PhIP following a 24h treatment (Figure 4b). 169 
It should be noted that EROD activity cannot be measured at 10
-5
M BaP or above, as this is at or 170 
above the Km for CYP1A1 and thus BaP outcompetes 7-ER for the CYP active site and 7-ER is not 171 
metabolised to fluorescent resosrufin to any great extent. 172 
 173 
CYP1A1 mRNA 174 
Q-PCR for CYP1A1 mRNA following a 48h recovery period post-treatment showed sustained 175 
induction at the combinations 10
-6
M BaP + 10
-6
M PhIP, 10
-6
M BaP + 10
-5
M PhIP, 10
-5
M BaP + 10
-6
M 176 
PhIP, 10
-5
M BaP + 10
-4
M PhIP (Figure 5), consistent with the EROD data. 177 
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 178 
Discussion 179 
Eating cooked red meat correlates with diet-associated cancer and the cooking process leads to the 180 
formation of powerful chemical carcinogens such as BaP and PhIP 
1, 22
. Genotoxicity testing of 181 
chemical carcinogens has focussed largely on individual chemicals, using traditional regulatory-182 
approved mammalian cell assays involving two-dimensional (2D) cell culture. There is a large gap 183 
between 2D cell culture and the whole animal, and three-dimensional (3D) cell culture, shown to 184 
better represent in vivo tissue structure, may bridge the gap. Thus the aim of the current study was 185 
to use human mammary cell 3D spheroids to characterise the DNA damage response following 186 
exposure to mixtures of the mammary carcinogens BaP and PhIP. 187 
The results from the MN assay with BaP indicate that in human mammary cell line MCF-7 spheroids, 188 
this compound induces a statistically significant increase in MN at 10
-6
M and 10
-5
M, which is in line 189 
with previous studies, although there the cytokinesis block MN assay (CBMN) was employed 
23, 24
. In 190 
contrast to BaP, PhIP significantly increased MN only at 10
-4
M, and at a lower magnitude than BaP. It 191 
should be noted that it was not possible to test higher concentrations of PhIP due to solubility 192 
problems. PhIP has previously been shown to induce MN at concentrations from 0.5µM - 6 µM, but 193 
using the cytokinesis block MN (CBMN) assay 
23, 24
. It has been suggested that the mononucleate 194 
assay (no CBMN block) is less sensitive than the binucleate assay (CBMN block), possibly due to the 195 
latter only considering cells that have divided following cytochalasin B addition, whereas the 196 
mononucleate assay considers all intact cells 
25
, which may underestimate the MN frequency and 197 
thus explain the lower concentrations required to induce MN in the CBMN assay. Moreover, these 198 
published studies were conducted in 2D culture, whereas the current study used 3D spheroids, 199 
which may alter the toxicodynamics and thus the MN induction observed following treatment. This 200 
may explain the difference in the levels of PhIP-induced MN between our study and the published 201 
studies of Kalantzi et al. 
23
 and Hewitt et al., 
24
.  202 
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Induction of MN is observed for the combination 10
-7
M BaP with 10
-6
M PhIP, but then levels of MN 203 
decrease with increasing concentrations of BaP in the mixtures. Indeed, a significant decrease in MN 204 
levels observed between this concentration combination (10
-7
 M BaP + 10
-6
 M PhIP) and that of 10
-
205 
5
M BaP with 10
-4
M PhIP, despite these concentrations significantly inducing MN individually (26 and 206 
14 MN/1000 cells for BaP and PhIP respectively). In support, we have previously shown using the TK 207 
forward mutation assay in human lymphoblastoid MCL-5 cells that mixtures of BaP with PhIP in 208 
these concentration combinations produce a similar mutation profile to that we observed with 209 
mixtures here 
11
. In our previously published study, this effect was found to be mediated, at least in 210 
part, by the CYP1A family of enzymes, which activate both BaP and PhIP to their ultimate genotoxic 211 
metabolites, since correlations were observed between EROD activity or CYP1A1 mRNA and 212 
mutation profile. While BaP is predominantly metabolised by CYP1A1, metabolic activation of PhIP in 213 
humans is catalysed mainly by CYP1A2 
26
, leading to the formation of N-hydroxy PhIP (N-OH-PhIP), 214 
which is further metabolised by N-acetyltransferases or sulfotransferases to the ultimate reactive 215 
species that reacts with DNA. However, whilst MCF-7 cells express CYP1A1 and 1A2 mRNA, we have 216 
found that PhIP has limited ability to induce either CYP1A1 or CYP1A2 in this cell line (data not 217 
shown), and this, along with the limited induction of MN by PhIP in the current study suggests that 218 
CYP1A1 activation of BaP is the predominant mechanism for induction of micronuclei following 219 
exposure to the mixtures. Therefore, EROD activity and CYP1A1 mRNA expression were measured in 220 
the current study. EROD activity was shown to be significantly induced by the combination 10
-6
M 221 
BaP with 10
-6
M PhIP, where a significant induction of MN was also observed. However, although a 5 222 
fold induction of EROD activity was observed for the combination 10
-7
M BaP with 10
-6
M PhIP, this 223 
was 9 times lower than that for 10
-6
M BaP with 10
-6
M PhIP, where a smaller induction of MN was 224 
observed compared to 10
-7
M BaP with 10
-6
M PhIP.  225 
Interestingly, when the level of EROD activity following treatment with selected concentration 226 
combinations of BaP with PhIP was compared to the level observed for the corresponding 227 
concentration of BaP alone, it was found that  EROD  was lower in the mixture treated cells. For 228 
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example, EROD activity was almost 3 times higher following treatment with 10
-7
M BaP alone as with 229 
10
-7
M BaP in combination with 10
-6
M PhIP. A possible explanation for reduced induction of CYP1A1 230 
following treatment with selected mixtures is that PhIP is oestrogenic and can mediate gene 231 
transcription via the oestrogen receptor (ER) alpha 
27
. Aryl hydrocarbon Receptor Nuclear Translator 232 
(ARNT) is recruited to oestrogen-responsive promoters in the presence of oestradiol 
28
, thus, PhIP 233 
may be recruiting ARNT to the ER, reducing its availability, and hence signalling, through the AhR, 234 
which could explain the reduction in CYP1A (EROD) activity in the current study. This reduced EROD 235 
activity compared to BaP alone may play a role in the lower MN induction observed with the 236 
mixtures as compared to the individual compounds.  237 
The induction of CYP1A is unlikely to be the only factor involved in the response seen, however. In 238 
our previous mixtures study, involvement of cell cycle arrest and mismatch repair was found to play 239 
a role, thus these factors may also be involved in the response in spheroid culture, and warrant 240 
investigation. Moreover, since PhIP is known to induce CYP1B1, it would be of interest to measure 241 
expression of this CYP following treatment with PhIP and the mixtures of BaP with PhIP to 242 
investigate whether this plays a role in the response observed. 243 
Conclusion 244 
We have shown that the MN assay can be successfully applied to spheroids of MCF-7 cells to detect 245 
DNA damage induced by chemicals that are genotoxic to mammary cells, both individually and in 246 
mixtures. In support, the MN assay has recently been applied to spheroids of colon cancer cells 
16
 247 
and human reconstructed skin 
29
, thus the current study further validates the applicability of the MN 248 
assay to 3D culture. 249 
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Tables 304 
Table 1. Comparison of a 48h and 72h recovery period for the micronucleus assay following 305 
treatment of three dimensional spheroids of MCF-7 cells with increasing doses of Benzo[a]pyrene 306 
(BaP). 307 
Concentration of 
BaP 
Number of micronuclei per 1000 cells 
48h Recovery 72h Recovery 
DMSO 3.5 17.8 
10
-10
M 11.2 18.5 
10
-9
M 10.5 17.8 
10
-8
M 13.0 17.8 
10
-7
M 16.3 16.0 
10
-6
M 19.7 23.5 
10
-5
M 26.0 31.3 
 308 
 309 
 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
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Figure legends 318 
Figure 1 319 
Photographs of three dimensional (3D) spheroids in culture in AlgiMatrix system following 3, 10 and 320 
15 days growth. 321 
Figure 2 322 
Cell viability and number of micronuclei (MN) per 1000 cells following a 24 hour exposure of 323 
spheroid cultures of MCF-7 cells to increasing concentrations of (a) BaP or (b) PhIP, with a 48 hour 324 
recovery period following treatment. Viability is represented by the line graph, MN per 1000 cells as 325 
the bar graph. Data are presented as means ± SEM, n=2-3. Significance compared to the DMSO 326 
control (one-way ANOVA with Dunnett’s post-test; * P≤0.05, ** P≤0.01). 327 
Figure 3 328 
(a) Cell viability and number of micronuclei (MN) per 1000 cells following a 24 hour exposure of 329 
spheroid cultures of MCF-7 cells to BaP/PhIP mixtures. (b) Background corrected number of MN per 330 
1000 cells following a 24h exposure of spheroid cultures of MCF-7 cells to BaP/PhIP mixtures; in (b) 331 
black bars are MN values following exposure to PhIP, dark grey bars are MN values following 332 
exposure to BaP, light grey bars are MN values following exposure to the mixture. For all mixtures, 333 
the concentration of BaP is stated first. Data are means ± SEM, n=2-3. Significance compared to 334 
DMSO control (one-way ANOVA with Dunnett’s post-test; * P≤0.05, ** P≤0.01). 335 
Figure 4 336 
Ethoxyresorufin-O-deethylase (EROD) activity following a 24h treatment with (a) BaP or (b) 337 
combinations of BaP (concentration indicated first) and PhIP. Data are means ± SEM, n=3. 338 
Significance compared to the DMSO control (one-way ANOVA with Dunnett’s post-test; ** P≤0.01, 339 
*** P≤0.001, **** P≤0.0001). 340 
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 341 
Figure 5 342 
CYP1A1 mRNA levels (Q-PCR, normalised to GAPDH) following a 24 hour treatment to the BaP/PhIP 343 
mixture and a 48 hour recovery period. Data are means ± SEM, n=3. Significance compared to the 344 
DMSO control (one-way ANOVA with Dunnett’s post-test; ** P≤0.01, *** P≤0.001). 345 
 346 
 347 
 348 
 349 
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BaP +
PhIP
Low concentration of 
BaP in the mixture, high 
number of  micronuclei
High concentration of 
BaP in the mixture, low 
number of micronuclei
3D culture
The micronucleus (MN) assay can be successfully applied to spheroids of MCF-7 cells to 
detect DNA damage.
Page 25 of 25 Toxicology Research
